title: Is N-terminal pro-brain natriuretic peptide superior to clinical scores for risk stratification in non-massive pulmonary embolism?
authors.forename: N
authors.initials: N
authors.lastname: Vuilleumier
authors.forename: G
authors.initials: G
authors.lastname: Le Gal
authors.forename: J C
authors.initials: JC
authors.lastname: Cornily
authors.forename: D
authors.initials: D
authors.lastname: Hochstrasser
authors.forename: H
authors.initials: H
authors.lastname: Bounameaux
authors.forename: D
authors.initials: D
authors.lastname: Aujesky
authors.forename: M
authors.initials: M
authors.lastname: Righini
mesh_terms: D015415:Biomarkers / Q000097:blood*; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D011655:Pulmonary Embolism / Q000097:blood*; D018570:Risk Assessment; D012680:Sensitivity and Specificity
chemical_list: D015415:Biomarkers; D010446:Peptide Fragments; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain